Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tecan Group AGLTS:0QLN -0.36%73 Earnings per Share (Diluted) is CHF-9.16 as of Jun. 2026. GuruFocus rates LTS:0QLN with a GF Score™ of 73/100 and a GF Value™ of CHF188.21 (Fairly Valued). The stock has 8 warning signs investors should review. Among 656 Medical Devices & Instruments companies, Tecan Group AG ranks worse than 152438.87% on this metric.
Tecan Group AG's EPS (Basic) for the
six
months ended in Jun. 2026 was CHF0.99.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was CHF-9.16.
During the past 13 years, Tecan Group AG's highest 3-Year average EPS without NRI Growth Rate was 57.40% per year. The lowest was -21.30% per year. And the median was 8.30% per year.
Tecan Group AG (LTS:0QLN) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Tecan Group AG Earnings per Share (Diluted) Related Terms
Tecan Group AG Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Tecan Group AG's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QLN vs ISRG, BDX, MDLN: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, Tecan Group AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's PE Ratio distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's PE Ratio falls into.
Tecan Group AG Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Tecan Group AG's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-9.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of CHF-9.16 mean?
Tecan Group AG (LTS:0QLN) has a Earnings per Share (Diluted) of CHF-9.16 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Tecan Group AG and its competitors. According to the industry distribution chart, Tecan Group AG ranks #999999 out of 656 companies in the Medical Devices & Instruments industry.
Is Tecan Group AG's Earnings per Share (Diluted) too high?
Tecan Group AG's current Earnings per Share (Diluted) is CHF-9.16. Based on the distribution chart, Tecan Group AG ranks #999999 out of 656 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tecan Group AG has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's Earnings per Share (Diluted) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tecan Group AG ranks #999999 out of 656 companies for Earnings per Share (Diluted). This places Tecan Group AG in the lower half of its industry. The industry median Earnings per Share (Diluted) is 8.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 8.05, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Tecan Group AG and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tecan Group AG's current Earnings per Share (Diluted) is CHF-9.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (LTS:0QLN) is currently considered Fairly Valued. The stock's GF Value™ is CHF188.21, compared to a current price of CHF192.22 — trading 2.1% above its estimated fair value. The current Earnings per Share (Diluted) is CHF-9.16. Tecan Group AG's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Tecan Group AG (LTS:0QLN), the current Earnings per Share (Diluted) is CHF-9.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tecan Group AG (LTS:0QLN) Overvalued in 2026?
Based on GuruFocus' analysis, Tecan Group AG stock appears to be overvalued.
The current stock price of CHF192.22 is trading 2.1% above its estimated GF Value™ of CHF188.21.
GuruFocus considers Tecan Group AG to be Fairly Valued.
Key valuation signals for LTS:0QLN:
Earnings per Share (Diluted): CHF-9.16
GF Value™: CHF188.21 vs. price of CHF192.22 (2.1% above fair value)
No single metric tells the full story. See the LTS:0QLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
73GF Score
Get the complete analysis for LTS:0QLN
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLN has been successfully added to your 
